Drug Type Small molecule drug |
Synonyms Propranolol/etodolac, VT 11CR, VT-122 |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), β-adrenoceptors antagonists(Beta adrenergic receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC17H21NO3 |
InChIKeyNNYBQONXHNTVIJ-UHFFFAOYSA-N |
CAS Registry41340-25-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Colorectal Carcinoma | Phase 2 | IL | 28 Feb 2019 | |
Hepatocellular Carcinoma | Phase 2 | US | 01 Dec 2010 | |
Inflammation | Phase 2 | US | 01 Dec 2010 | |
Cachexia | Phase 2 | US | 01 Jan 2007 | |
Cachexia | Phase 2 | IN | 01 Jan 2007 | |
metastatic non-small cell lung cancer | Phase 2 | US | 01 Jan 2007 | |
metastatic non-small cell lung cancer | Phase 2 | IN | 01 Jan 2007 |